Medmix Ltd
SIX:MEDX
Medmix Ltd
SIX:MEDX
Price:
16.36 CHF
0.37%
Market Closed
Updated:
May 18, 2024
Medmix Ltd
Cost of Revenue
|
Medmix Ltd
Cost of Revenue Peer Comparison
Comparables:
METN
SOON
MOVE
STMN
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Medmix Ltd
SIX:MEDX
|
Cost of Revenue
-CHf301.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Cost of Revenue
-CHf343.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Sonova Holding AG
SIX:SOON
|
Cost of Revenue
-CHf1B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
|
Medacta Group SA
SIX:MOVE
|
Cost of Revenue
-€162.9m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Straumann Holding AG
SIX:STMN
|
Cost of Revenue
-CHf623.4m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Medmix Ltd's Cost of Revenue?
Cost of Revenue
-301.7m
CHF
-301.7m
CHF
Based on the financial report for Dec 31, 2022, Medmix Ltd's Cost of Revenue amounts to -301.7m CHF.
What is Medmix Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-5%
-5%
Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Medmix Ltd have been -5% over the past three years .
You don't have any saved screeners yet
